2019
DOI: 10.15537/smj.2019.1.23892
|View full text |Cite
|
Sign up to set email alerts
|

Celiac disease among at-risk individuals in Saudi Arabia

Abstract: Objectives: To perform a meta-analysis for celiac diseases (CD) among at-risk populations in Kingdom of Saudi Arabia (KSA), as well as a comparison with our previously reported meta-analysis in the normal population. Methods: In March 2018, at King Abdulaziz University, Jeddah, KSA we commenced a retrospective comprehensive database and journal search for CD among at-risk populations in SA. Data from each of the relevant articles were analyzed using the Statistical Pack… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 34 publications
0
11
0
1
Order By: Relevance
“…17 A recent systematic review evaluated the prevalence of CeD in patients with short stature in Saudi Arabia. 52 They found an overall pooled seroprevalence of 16.1% and biopsy-proven prevalence of 6.75% in their studies. Of the five included studies in the above review, only one study was included in our review.…”
Section: Discussionmentioning
confidence: 86%
See 1 more Smart Citation
“…17 A recent systematic review evaluated the prevalence of CeD in patients with short stature in Saudi Arabia. 52 They found an overall pooled seroprevalence of 16.1% and biopsy-proven prevalence of 6.75% in their studies. Of the five included studies in the above review, only one study was included in our review.…”
Section: Discussionmentioning
confidence: 86%
“…were conducted before the standard definition of CeD was available 17 . A recent systematic review evaluated the prevalence of CeD in patients with short stature in Saudi Arabia 52 . They found an overall pooled seroprevalence of 16.1% and biopsy‐proven prevalence of 6.75% in their studies.…”
Section: Discussionmentioning
confidence: 99%
“…‡ F/M =60/29=2/1. § Two studies [8,10] in Riyadh region, four studies [9,11,12,13] in the western region and two studies [8,10] 12.0 *Meta analysis is in Table 5 and Table 7. studies).…”
Section: Results Characteristics Of the Patient Studiesmentioning
confidence: 99%
“…3,12 So far in the Kingdom of Saudi Arabia, only 8 studies concerning CD among T1DM were retrieved via a recent systematic review. 8,9 When Al-Ashwal et al 10 reported (in 2003) a prevalence of 4.9% for the biopsy-proven CD in T1DM in Kingdom of Saudi Arabia, at that time the worldwide prevalence (of CD in T1DM) was 1.2-11.1%, with the exceptions of Argentina (13.9%) and Algeria (16.4%). 20,21,[23][24][25]27,[34][35][36][37][38] In the current meta-analysis, 12.0% of T1DM individuals had biopsy-verified CD (95% CI: 10.2-14.0) with high heterogeneity (I 2 =82.7), which was double the global prevalence (6.0%); according to the systematic review (between 2000 and May 2014) of Elfstrom et al, 5 only one study reported a similarly high prevalence (12.3% in 2006) among Danish children; 39 in addition to Argentina (13.9%) and Algeria (16.4%), both in 1996.…”
Section: (1998) 24mentioning
confidence: 99%
See 1 more Smart Citation